|
146
|
699
|
6w2xA |
Cryoem structure of inactive gabab heterodimer |
|
179
|
696
|
6w2yA |
Cryoem structure of gabab1b homodimer |
|
166
|
698
|
6w2xB |
Cryoem structure of inactive gabab heterodimer |
|
170
|
698
|
6vjmA |
Human metabotropic gaba(b) receptor in its apo state |
|
169
|
697
|
6vjmB |
Human metabotropic gaba(b) receptor in its apo state |
|
165
|
697
|
6uo8A |
Human metabotropic gaba(b) receptor bound to agonist skf97541 and positive allosteric modulator gs39783 |
|
153
|
694
|
6uo9A |
Human metabotropic gaba(b) receptor bound to agonist skf97541 in its intermediate state 2 |
|
167
|
698
|
6uo9B |
Human metabotropic gaba(b) receptor bound to agonist skf97541 in its intermediate state 2 |
|
157
|
698
|
6uo8B |
Human metabotropic gaba(b) receptor bound to agonist skf97541 and positive allosteric modulator gs39783 |
|
168
|
697
|
6uoaB |
Human metabotropic gaba(b) receptor in its intermediate state 1 |
|
164
|
696
|
6uoaA |
Human metabotropic gaba(b) receptor in its intermediate state 1 |
|
202
|
808
|
6ruqA |
Structure of glua2cryst in complex the antagonist zk200775 and the negative allosteric modulator gyki53655 at 4.65 a resolution |
|
196
|
783
|
6lu9A |
Rat ionotropic glutamate delta-2 receptor in complex with 7-cka and calcium |
|
247
|
1029
|
6o9gA |
Open state glua2 in complex with stz and blocked by agtx-636, after micelle signal subtraction |
|
158
|
814
|
6mmxA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
175
|
804
|
6mmuB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
171
|
804
|
6mmtD |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
160
|
814
|
6mmiA |
Diheteromeric nmda receptor glun1/glun2a in the 'splayed-open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
162
|
804
|
6mmxB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
176
|
804
|
6mm9B |
Diheteromeric nmda receptor glun1/glun2a in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 |
|
169
|
804
|
6mmrB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar edta, and at ph 7.4 |
|
165
|
804
|
6mmlB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
162
|
804
|
6mmsB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar edta, and at ph 7.4 |
|
166
|
814
|
6mmrA |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar edta, and at ph 7.4 |
|
178
|
804
|
6mmmB |
Diheteromeric nmda receptor glun1/glun2a in the 'extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
173
|
804
|
6mmaB |
Diheteromeric nmda receptor glun1/glun2a in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 |
|
167
|
814
|
6mmpA |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar edta, and at ph 8.0 |
|
165
|
814
|
6mmlA |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
161
|
804
|
6mmpB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar edta, and at ph 8.0 |
|
177
|
804
|
6mmuD |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
157
|
814
|
6mmmA |
Diheteromeric nmda receptor glun1/glun2a in the 'extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
138
|
767
|
6mmvD |
Triheteromeric nmda receptor glun1/glun2a/glun2a* extracellular domain in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
169
|
804
|
6mmtB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
171
|
814
|
6mmwA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
159
|
814
|
6mmhA |
Diheteromeric nmda receptor glun1/glun2a in the 'extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
138
|
767
|
6mmvB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* extracellular domain in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
168
|
804
|
6mmkB |
Diheteromeric nmda receptor glun1/glun2a in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
162
|
814
|
6mm9A |
Diheteromeric nmda receptor glun1/glun2a in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 |
|
152
|
804
|
6mmjB |
Diheteromeric nmda receptor glun1/glun2a in the 'super-splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
171
|
804
|
6mmgB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar edta, and at ph 7.4 |
|
147
|
804
|
6mmbB |
Diheteromeric nmda receptor glun1/glun2a in the 'super-splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 |
|
159
|
814
|
6mmtA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
169
|
804
|
6mmwB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
146
|
814
|
6mmbA |
Diheteromeric nmda receptor glun1/glun2a in the 'super-splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 |
|
160
|
804
|
6mmiB |
Diheteromeric nmda receptor glun1/glun2a in the 'splayed-open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
130
|
773
|
6mmvA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* extracellular domain in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
168
|
804
|
6mmhB |
Diheteromeric nmda receptor glun1/glun2a in the 'extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
167
|
814
|
6mmgA |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar edta, and at ph 7.4 |
|
153
|
804
|
6mmnB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 8.0 |
|
161
|
814
|
6mmuA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
